首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Medical expenditures of adult cancer survivors aged <65 years in the United States.
【24h】

Medical expenditures of adult cancer survivors aged <65 years in the United States.

机译:在美国,年龄<65岁的成年癌症幸存者的医疗支出。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: To the authors' knowledge, this is the first study to provide national estimates of medical expenditures for all adult cancer survivors aged <65 years. Most studies of expenditures for cancer survivors in this age group have been based on the Medical Expenditure Panel Survey (MEPS) and were limited to "affected survivors." METHODS: MEPS expenditure data for 2001 to 2007 were linked to data identifying all survivors from the National Health Interview Survey (NHIS), which is the MEPS sampling frame. The sample was comprised of adults ages 25 to 64 years. Propensity-score matching was used to estimate the effects of cancer on average total and out-of-pocket expenditures for all services and separately for prescriptions. Probit models were used to estimate effects on the probability of exceeding different expenditure thresholds. RESULTS: Mean annual expenditures on all services in 2007 were Dollars 16,910 +/- Dollars 3911 for survivors who were newly diagnosed with cancer, Dollars 7992 +/- Dollars 972 for survivors who had been diagnosed in previous years, and Dollars 3303 +/- Dollars 103 for other adults. Fifty-three percent of survivors were not identified in MEPS but only by linking to NHIS. Expenditures for all survivors averaged approximately Dollars 9300 compared with Dollars 13,600 for "affected survivors." For previously diagnosed survivors, the increase in mean expenditures attributable to cancer was approximately Dollars 4000 to Dollars 5000 annually. On average, relatively little of the increase was paid out of pocket, but cancer nearly doubled the risk of high out-of-pocket expenditures. CONCLUSIONS: Previous MEPS analyses overstated average expenditures for all survivors. Nevertheless, the current results indicated that the increase in expenditures attributable to cancer is substantial, even for longer term survivors, and that cancer increases the relative risk of high out-of-pocket expenditures.
机译:背景:据作者所知,这是第一项为所有年龄在65岁以下的成年癌症幸存者提供医疗支出的国家估算的研究。对于这个年龄组的癌症幸存者的支出的大多数研究都是基于医疗支出小组调查(MEPS)进行的,并且仅限于“受影响的幸存者”。方法:将2001年至2007年的MEPS支出数据与从国家健康访问调查(NHIS)中识别所有幸存者的数据相关联,这是MEPS的抽样框架。样本包括25至64岁的成年人。倾向得分匹配用于估计癌症对所有服务以及处方的平均总支出和自付费用的影响。概率模型用于估计超过不同支出阈值的可能性的影响。结果:2007年所有服务的平均年度支出为:新诊断出癌症的幸存者为16910美元+/- 3911美元,往年被诊断为幸存者的7992美元+/- 972美元和3303美元+/-其他成年人103美元。在MEPS中未识别出53%的幸存者,而仅通过与NHIS的联系确定。所有幸存者的平均支出约为9300美元,而“受影响幸存者”的支出为13600美元。对于先前诊断的幸存者,癌症的平均支出每年增加约4000美元到5000美元。平均而言,增加的钱中很少有钱是自付的,但是癌症几乎使高额自付费用的风险增加了一倍。结论:先前的MEPS分析了所有幸存者夸大的平均支出。然而,目前的结果表明,即使对于长期幸存者来说,归因于癌症的支出增加也是可观的,并且癌症增加了自付费用的相对风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号